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Several proto-oncogenes and tumor suppressors
regulate the production of ribosomes. Ribosome
biogenesis is a major consumer of cellular energy,
and defects result in p53 activation via repression
of mouse double minute 2 (MDM2) homolog by the
ribosomal proteins RPL5 and RPL11. Here, we report
that RPL5 and RPL11 regulate p53 from the context
of a ribosomal subcomplex, the 5S ribonucleoprotein
particle (RNP). We provide evidence that the third
component of this complex, the 5S rRNA, is critical
for p53 regulation. In addition, we show that the 5S
RNP is essential for the activation of p53 by p14ARF,
a protein that is activated by oncogene overexpres-
sion. Our data show that the abundance of the 5S
RNP, and therefore p53 levels, is determined by fac-
tors regulating 5S complex formation and ribosome
integration, including the tumor suppressor PICT1.
The 5S RNP therefore emerges as the critical coordi-
nator of signaling pathways that couple cell prolifer-
ation with ribosome production.
INTRODUCTION
The production of eukaryotic ribosomes is a major consumer of
cellular energy and regulated by several tumor suppressors and
proto-oncogenes (Stumpf and Ruggero, 2011). Indeed, ribo-
some biogenesis is upregulated by the oncogene c-Myc, down-
regulated by the tumor suppressor p14ARF, and is linked to the
regulation of the tumor suppressor p53 (Stumpf and Ruggero,
2011). Several genetic diseases, such as Diamond-Blackfan
anemia, dyskeratosis congenita, and Treacher Collins syn-
drome, arise due to defects in ribosome production, and in a
number of cases, this has been linked to the misregulation of
p53 (Freed et al., 2010; Fumagalli and Thomas, 2011; Narla
and Ebert, 2010). Surprisingly, several of these diseases, which
are known as ribosomopathies, also predispose patients to a
range of cancers.
The tumor suppressor p53 is activated by a wide range of
cellular stresses, leading to either repair of the cellular damage,Ccell-cycle arrest, apoptosis, or senescence. A key regulator of
p53 is mouse double minute 2 homolog (MDM2), an E3 ubiquitin
ligase that inhibits p53 activity through proteasome-mediated
degradation. Several ribosomal proteins (RPs) bind to and inac-
tivate MDM2, thereby activating p53 (Chakraborty et al., 2011),
but recent work has shown that only RPL5 and RPL11 are essen-
tial for p53 activation in response to a block in ribosome biogen-
esis (Bursac et al., 2012; Fumagalli et al., 2012; Sun et al., 2010).
MDM2 mutations found in several cancers, which disrupt
the RPL11-MDM2 interaction, attenuate the p53-mediated
response to nucleolar/ribotoxic stress and accelerate c-Myc-
induced lymphomagenesis in a mouse model system (Macias
et al., 2010; Pan et al., 2011). RPL11 also binds to and promotes
the activity of the tumor suppressor p14ARF (Dai et al., 2012),
which interacts with and represses MDM2 and is activated by
the overexpression of oncogenes such as c-Myc.
Although RPL5 and RPL11 inhibit MDM2 outside the ribo-
some, it is unlikely that they perform this function individually,
as free ribosomal proteins are unstable in mammalian cells
(Lam et al., 2007). RPL11, together with RPL5 and the 5S
rRNA, comprise the 5S ribonucleoprotein particle (RNP), an
essential subcomplex of the large ribosomal subunit. RPL5
binds the 5S rRNA and the 5S rRNA/RPL5 complex and then
localizes to the nucleolus, where it binds RPL11 and is inte-
grated into the ribosome (Chakraborty et al., 2011). RPL5 and
RPL11 have been shown to be mutually dependent on one
another for stability/accumulation when ribosome biogenesis
is blocked (Bursac et al., 2012). Furthermore, it has been
demonstrated that RPL11 activates p53 cooperatively with
RPL5 and mutations, which are predicted to impede RPL11
interaction with the 5S rRNA, inhibit this induction (Horn and
Vousden, 2008).
Proteins that regulate 5SRNP formation, localization, and inte-
gration into the ribosome are predicted to be central in regulating
MDM2 activity and, therefore, p53 levels in the cell. PICT1
(GLTSCR2) has recently been identified as a novel tumor sup-
pressor that induces p53 and activates the PTEN pathway/
ATM checkpoint in response to DNA damage (Kim et al.,
2011). Interestingly, PICT1 has also been shown to retain
RPL11 in the nucleolus in normal cells. However, under ribotoxic
stress conditions, RPL11 and PICT1 relocalize to the nucleo-
plasm, where they activate p53 (Sasaki et al., 2011). Mechanistic
details on how PICT1 performs this function are currentlyell Reports 5, 237–247, October 17, 2013 ª2013 The Authors 237
Figure 1. The 5S RNP Complex Is Required
for p53 Induction through Direct Interaction
with MDM2 in Response to Ribotoxic Stress
(A) The level of newly synthesized 5S rRNA in cells
transfected with control siRNAs or those targeting
TFIIIA or the 5S rRNA itself was determined by
pulse-labeling followed by gel electrophoresis.
Quantification is based on three independent
experiments. Error bars indicate SD.
(B) U2OS cells were transfected with siRNAs
against the core 5S RNP components and either
untreated () or treated (+) with ActD for 10 hr. p53
levels were analyzed by western blotting. Quanti-
fication is based on three independent experi-
ments. Error bars indicate SD.
(C) Anti-FLAG immunoprecipitations of extracts
from HEK293 cells expressing FLAG-MDM2,
-MDM2C305F, or the FLAG-tag. Coprecipitated 5S
and 5.8S rRNAs were detected by northern blot-
ting. IgG, immunoglobulin G.
(D) Cells expressing FLAG-tagged proteins
were UV crosslinked, and covalently linked RNA
protein complexes were purified. Coprecipitated
5S and 5.8S rRNAs were detected by northern
blotting.
See also Tables S1, S2, and S3 and Figure S1.lacking, but because this protein is in fact homologous to the
yeast ribosome biogenesis factor Nop53, we hypothesize that
it may activate p53 through a role in ribosome biogenesis.
Several other factors have been linked to the formation of the
5S RNP and its integration into the ribosome in yeast, making
these good candidates for performing this role, but their human
counterparts are yet to be characterized (Talkish et al., 2012;
Zhang et al., 2007). Furthermore, how the function of RPL11
and RPL5 in p53 signaling relates to their role in ribosome pro-
duction also remains unclear at present, but it is exciting to spec-
ulate that their dual function reflects a coordinated pathway
coupling ribosome biogenesis to cell proliferation.
Given the importance of RPL11 and RPL5 as components of
the p53 signaling pathway (Chakraborty et al., 2011), 5S RNP
biology is an underinvestigated area of research that is relevant
for understanding the basis of many human ribosomopathies.
We show that the 5S rRNA, as part of an assembled 5S RNP
complex, is essential for p53 homeostasis and p53 activation
when p14ARF is expressed. Our data indicate that the 5S RNP
functions as a central regulator of p53, providing a means to
directly relate ribosome biogenesis to cellular growth and cell-
cycle regulation.
RESULTS
The 5S rRNA, Together with RPL11 and RPL5, Is
Required for p53 Homeostasis and the Activation of p53
when Ribosome Biogenesis Is Inhibited
MDM2 is a critical negative regulator of p53 levels and the ribo-
somal proteins RPL5 and RPL11 have been shown to inhibit
MDM2 activity when ribosome biogenesis is blocked, leading
to p53 activation. During ribosome biogenesis, RPL5 and238 Cell Reports 5, 237–247, October 17, 2013 ª2013 The AuthorsRPL11 both associate with the 5S rRNA to form the 5S RNP,
an essential subcomplex of the ribosome. To investigate the
importance of the 5S rRNA in regulating MDM2/p53, two paral-
lel approaches were taken to decrease the production of the 5S
rRNA in U2OS cells and to monitor the effect on p53 levels: the
5S rRNA-specific transcription factor IIIA (TFIIIA) was depleted
by RNAi and the 5S rRNA itself was directly targeted using
siRNAs (Li and Gu, 2011). The effect of depleting RPL5 and
RPL11 by RNAi on p53 levels was also analyzed for compari-
son (Figure 1 and Figure S1A). Decreasing TFIIIA to <5% of
the normal level (Figure S1A) resulted in an approximately 3-
fold reduction in 5S rRNA production in pulse-labeling experi-
ments, whereas direct targeting of the 5S rRNA reduced 5S
rRNA synthesis to about 60% of that seen in control cells
(Figure 1A).
If components of the 5S RNP are required for p53 activation
when ribosome production is blocked, depletion of these factors
should diminish p53 induction by the chemotherapeutic agent
Actinomycin D (ActD), which blocks rRNA synthesis by inhibiting
RNA polymerase I. Interestingly, knockdown of RPL11, RPL5,
TFIIIA, or the 5S rRNA all resulted in a reduction in the basal
levels of p53 in untreated U2OS cells, suggesting that these 5S
RNP components are required for maintaining cellular p53 levels
(Figure 1B). In addition, treatment of cells with ActD caused the
accumulation of p53 (approximately 4-fold), but reducing the
levels of RPL5 or RPL11 eradicated this induction. Decreasing
5S rRNA levels also reduced but did not abolish ActD-mediated
p53 activation (Figure 1B). This is consistent with the fact that 5S
rRNA synthesis was only diminished and not eradicated (Fig-
ure 1A). Taken together, our data show that the 5S rRNA,
together with RPL5 and RPL11, is required for ActD induction
of p53 and p53 homeostasis in normal cells.
Figure 2. A 5S RNP Complex Containing 5S rRNA, RPL5, and RPL11 Only Accumulates in the Nucleoplasm when Ribosome Production Is
Inhibited
(A) Extracts from HEK293 cells either treated (+) or untreated () with ActD were analyzed by glycerol gradient centrifugation followed by western and northern
blotting. Antibodies or probes used are indicated to the left of each panel.
(B) Levels of 5S and 5.8S rRNAs in free (pooled fractions 1–7) and ribosomal (pooled fractions 9–20) complexes in various cell lines were analyzed by northern
blotting. Primary, primary dermal fibroblasts.
(C) RNA from HeLa cell nuclear and cytoplasmic extracts was separated by polyacrylamide gel electrophoresis and detected using ethidium bromide staining.
(D) The localization of newly synthesized FLAG-RPL5 or -RPL11 in HEK293 stable cell lines was determined by immunofluorescence. Cells were grown in the
presence (ActD) or absence (control) of ActD, and antibodies against the FLAG-tag (red/greyscale) and fibrillarin (green; nucleolar marker) were used. Nuclear
material was detected by DAPI staining (blue). The scale bar represents 1 mm.
See also Tables S2 and S3 and Figure S2.MDM2 Directly Contacts the 5S rRNA
RPL11 and RPL5 activate p53 by binding to and inhibitingMDM2
(Chakraborty et al., 2011). We next asked whether the 5S rRNA is
also specifically associated with MDM2. For this, human embry-
onic kidney 293 (HEK293) cells stably expressing inducible
FLAG-MDM2 and an MDM2 mutant (C305F), which is not able
to interactwithRPL5andRPL11 (Maciaset al., 2010),weregener-
ated (Figure S1B). Immunoprecipitation experiments using whole
cell extracts revealed that FLAG-MDM2 was associated with the
5S rRNA, but not the 5.8S rRNA (Figure 1C). Importantly, the
amount of 5S rRNAcoprecipitated fromextractswas significantly
higher after cells were treated with ActD. Neither 5S rRNA nor
5.8S rRNA coprecipitated with FLAG-MDM2C305F indicating that
the 5S rRNA-MDM2 association is dependent on the binding of
RPL11 and RPL5 to MDM2. Importantly, the specific association
ofMDM2with the 5S rRNAwas also observed by immunoprecip-
itation using MDM2-specific antibodies from U2OS cell extracts
(Figure S1C).
MDM2 has been demonstrated to bind both RPL11 and RPL5
raising the possibility that MDM2, which has previously been
shown to bind RNA (Elenbaas et al., 1996), may also directly con-
tact the 5S rRNA. To test this, cells expressing FLAG-tagged
MDM2, MDM2C305F, RPL5, or the FLAG tag alone (Figure S1B)
were irradiated with UV light. Cells expressing FLAG-MDM2 or
MDM2C305F that had been treated with ActD were also included.
The proteins, and any covalently bound RNAs, were then isolated
fromextractsderived from thesecellsusingadenaturing two-stepCpurification procedure, and the associated RNAs were analyzed
by northern blotting. The 5S rRNAwas found to crosslink strongly
to RPL5, as expected, but also specifically to MDM2 (Figure 1D).
Consistent with our immunoprecipitation data, the amount of 5S
rRNA crosslinked to MDM2 increased when cells were treated
with ActD and the MDM2C305F mutation abolished this interac-
tion. These data demonstrate that, in addition to directly binding
RPL11 and RPL5, MDM2 also directly contacts the 5S rRNA.
The 5S RNP, a Complex of RPL5, RPL11, and the 5S
rRNA, Accumulates when Ribosome Biogenesis Is
Blocked
Our data imply that, rather than functioning individually, the 5S
rRNA, RPL11, and RPL5 act as a complex to activate p53. How-
ever, how these factors accumulate outside the ribosome in
human cells, and how this is affected when ribosome biogenesis
is blocked, is currently unknown. We used glycerol gradient
centrifugation to define 5S RNP complexes that exist in normal
cells and in cells in which ribosome production has been per-
turbed by treatment with ActD.
In untreated HEK293 cells, the 5S rRNA, RPL11, and RPL5
were present in complexes containing mature large ribosomal
subunits (indicated by the position of the 5.8S rRNA; Figure 2A;
fractions 9–18). These fractions also contained ribosomebiogen-
esis factors, such as RBM28 (Figure S2A) and therefore preribo-
somal complexes. A significant proportion of RPL5 and the 5S
rRNA were found in fractions 2–4 (Figure 2A) demonstratingell Reports 5, 237–247, October 17, 2013 ª2013 The Authors 239
that they are naturally present in nonribosomal fractions. The
relatively high level of free 5S rRNA was not specific to HEK293
cells but also observed in HeLa, U2OS, MCF7, and primary
human fibroblast cells (Figure 2B). Interestingly, RPL11 only
significantly accumulated in this free pool after the cells were
treated with ActD (Figure 2A). Consistent with our earlier data
identifying interactions between 5S RNP components and
MDM2 (Figures 1C and 1D), FLAG-MDM2 expressed in
HEK293 cells also comigrated with RPL5, RPL11, and the 5S
rRNA in the free fractions of a glycerol gradient, but not in the
ribosomal fractions (Figure S2B). Immunoprecipitation using ex-
tracts from stable cell lines expressing FLAG-tagged RPL5/
RPL11 was used to confirm that the comigrating RPL5, RPL11,
and 5S rRNA in fractions 2–4 form a stable complex (Figures
S1B and S2C). Interestingly, none of the ribosome biogenesis
factors analyzed, including RRS1 and BXDC1, which are associ-
ated with a free 5S RNP when ribosome biogenesis is blocked in
yeast (Zhang et al., 2007), were present in the free fractions under
any of the conditions tested (Figure S2A).
Taken together, these data indicate that the 5S rRNA, RPL5,
and RPL11 components, together with MDM2, are present as
a complex in the free fractions of the gradient and that the
amount of RPL11 in this complex increases when ribosome
biogenesis is blocked.
The 5S RNP Accumulates in the Nucleoplasm when
Ribosome Production Is Inhibited
Our data demonstrate that a free 5S RNP accumulates when
ribosome biogenesis is blocked. This complex interacts with
MDM2, but it is not clear where this interaction takes place.
RPL11 and RPL5 were predicted to repress MDM2 in the nucle-
oplasm (Chakraborty et al., 2011), but a recent report suggested
that the RPL5/RPL11/MDM2 complex accumulates in the nucle-
olus when ribosome biogenesis is blocked (Bursac et al., 2012).
We investigated the subcellular distribution of the 5S RNP. Anal-
ysis of the RNA content of nuclear and cytoplasmic extracts
revealed a high level of the 5S rRNA in the nucleoplasm (Fig-
ure 2C). These nuclear extracts do not contain nucleolar material
(Watkins et al., 2004) indicating that the 5S rRNA is present in the
nucleoplasm at levels higher than the spliceosomal U5 snRNA
(200,000 copies/cell; Reddy and Busch, 1988).
To determine the localization of newly synthesized RPL11 and
RPL5, we used immunofluorescence to analyze HEK293 cells
expressing tetracycline-regulated FLAG-tagged RPL11 and
RPL5, in the presence or absence of ActD to block ribosome pro-
duction. Importantly, the FLAG-tagged proteinswere not overex-
pressed and showed the same profile on glycerol gradients as
the endogenous proteins (Figures S1B and S2B). In control cells,
RPL11 was predominantly present in the cytoplasm and nucle-
olus, whereas RPL5 was found throughout the cell with signifi-
cant levels present in the nucleolus and nucleoplasm (Figure 2D).
After treatment with ActD, there was a significant increase in
RPL11 levels in the nucleoplasm and a major decrease in the
levels of both RPL5 and RPL11 in the nucleolus (Figure 2D).
This suggests that active ribosome biogenesis is required for
the nucleolar localization/retention of both RPL5 and RPL11.
Taken together, our data indicate that the 5S/RPL5 complex
is naturally abundant in the nucleoplasm but that the 5S RNP240 Cell Reports 5, 237–247, October 17, 2013 ª2013 The Authors(5S rRNA/RPL5/RPL11) accumulates in the nucleoplasm when
ribosome biogenesis is blocked. Along with RPL5 and RPL11,
the 5S rRNA interacts with MDM2, implying that the trimeric 5S
RNP complex binds MDM2 in the nucleoplasm to affect p53
levels. Modulating the levels of the 5S RNP directly controls
MDM2 activity. Consequently, the pathways that mediate 5S
RNP formation, localization, and integration into the ribosome
are central for regulating p53 levels and cellular proliferation.
Factors Linked to 5S RNPBiogenesis and p53 Activation
through the RPL5/RPL11 Pathway Are Important for the
Production of the Large Ribosomal Subunit
The nucleolar protein PICT1 has recently emerged as a key regu-
lator of p53 and has been proposed to function by retaining
RPL11 in the nucleolus (Sasaki et al., 2011). Similarly, the puta-
tive tumor suppressor PAK1IP1 is suggested to act through
the ribosomal protein-MDM2 pathway, but it is currently
unknown whether these factors function as regulators of the
interaction of the 5S RNP with MDM2 or whether they perform
these roles as components of the ribosome biogenesis machin-
ery. We therefore investigated the role of several nucleolar pro-
teins linked either to p53 regulation (PICT1 and PAK1IP1) or
known to be important for 5S RNP integration into ribosomes
in yeast (RRS1, BXDC1, and NOP2) in ribosome biogenesis in
human cells. We also analyzed the importance of the 5S RNP
components RPL5, RPL11, and the 5S rRNA for ribosome pro-
duction. Individual proteins or the 5S rRNA were depleted using
RNAi, and the production of newly synthesized ribosomes was
determined by pulse-chase labeling of mature (18S, 28S, and
5.8S) and precursor (47S/45S and 32S) rRNAs (Figure 3A) fol-
lowed by agarose-glyoxal or polyacrylamide gel electrophoresis
(Figures 3B, S1A, and S3A).
Reducing the levels of RPL5, RPL11, PICT1, RRS1, or NOP2
resulted in a dramatic reduction in the production of the 28S
and 5.8S rRNAs with minimal effects on 18S rRNA accumulation
(Figure 3B). This is similar to the effect seen upon knockdown of
the large ribosomal subunit biogenesis factor, BOP1 (Ho¨lzel
et al., 2005; Strezoska et al., 2000; Figure 3B). Knockdown of
BXDC1, PAK1IP1, TFIIIA, or 5S rRNA also specifically decreased
accumulation of the large subunit rRNAs, 28S and 5.8S, although
to a lesser extent than with the other knockdowns. Interestingly,
even though the siRNAs targeting TFIIIA and the 5S rRNA only
had minimal effects on 5S rRNA synthesis (Figures 1A and 3B),
this was sufficient to reduce 28S and 5.8S rRNA accumulation
demonstrating that production/incorporation of the 5S RNP is
required for large ribosomal subunit formation.
Whereas most of the knockdowns had a significant effect on
28S and 5.8S rRNA accumulation, their effect on 5S rRNA pro-
duction was minimal implying that the accumulation of the 5S
rRNA, which is transcribed by RNA pol III, occurs independently
of the RNA pol I-transcribed rRNAs. Indeed, ActD inhibition of
RNA pol I transcription or blocking pre-rRNA processing by
treatment with 5-fluorouracil (5FU) had no notable effect on 5S
rRNA accumulation (Figure 3C). Knockdown of RPL5, however,
resulted in a significant reduction in 5S rRNA levels and the accu-
mulation of a smear of longer 5S pre-rRNAs (Figure 3D). After
transcription, the 5S rRNA undergoes 30 processing to remove
a 2 to 3 nt extension (Ciganda and Williams, 2011), and our
Figure 3. Putative 5S RNP Biogenesis Factors Are Required for Large Ribosomal Subunit Production and Their Depletion Activates p53
(A) Outline of the major pre-rRNA processing pathway in humans.
(B and C) HEK293 cells depleted of 5S RNP components or putative 5S biogenesis factors by RNAi, or treated with chemotherapeutics (ActD and 5FU), were
pulse-labeled using 32P orthophosphate. Labeled RNA was analyzed by agarose/acrylamide gel electrophoresis followed by phosphorimager analysis. Total
RNA was visualized using ethidium bromide staining.
(D) Magnification of the pre-5S rRNA in cells depleted of RPL5 from (B).
(E) p53 levels in U2OS cells depleted of ribosome biogenesis factors were determined by western blotting. The antibodies used are indicated to the left of the
panels.
See also Tables S1 and S3 and Figure S3.data indicate that RPL5 is essential for this maturation as well as
for 5S rRNA accumulation.
Depletion of a ribosome biogenesis factor would block ribo-
some production, leading to increased accumulation of the 5S
RNP and therefore cause activation of p53. However, if a ribo-
some biogenesis factor was also required for MDM2 regulation,
depleting this protein would have no effect on p53 levels in the
cell. Indeed, knockdown of RPL11 or RPL5 did not increase
the levels of p53 or its downstream target, p21, even though
these knockdowns efficiently blocked large ribosomal subunit
production (Figures 3B and 3E). In contrast, depleting BOP1,
RRS1, BXDC1, PAK1IP1, PICT1, or NOP2 in U2OS cells resulted
in significant increases in the levels of p53 and p21 (Figure 3E).
Furthermore, p53 activation by the knockdown of factors such
as PICT1 was nullified by the codepletion of RPL5 or RPL11 con-
firming that they function through the 5S RNP/MDM2 pathway
(Figure S3B).
Taken together, our data demonstrate that knockdown of fac-
tors required for the synthesis of the large ribosomal subunit,
other than components of the 5S RNP, results in the activation
of p53.
RRS1 and BXDC1 Are Important for the Nucleolar
Localization of the 5S RNP
Blocking ribosome biogenesis using ActD resulted in the accu-
mulation of the 5S RNP in the nucleoplasm (Figure 2D). ActD
causes a major change in the nucleolar structure, and we there-Cfore wanted to test whether knockdown of individual ribosome
biogenesis factors also leads to the relocalization of the 5S
RNP. We therefore next examined whether any of the putative
5S RNP biogenesis factors that are essential for the production
of the large ribosomal subunit are also required for the nucleolar
localization of RPL5 and RPL11. To allow analysis of the locali-
zation of RPL5 and RPL11 produced only after the biogenesis
factors were depleted, HEK293 cells expressing inducible
FLAG-RPL5 or FLAG-RPL11 were transfected with siRNAs,
and 36 hr later, expression of the tagged-protein was induced.
Consistent with our previous data (Figure 2D), RPL11 was pre-
dominantly found in the nucleolus (Figure 4; marker: fibrillarin)
and cytoplasm of control cells and did not significantly accumu-
late in the nucleoplasm, whereas RPL5 localized throughout the
cell. Knockdown of either RRS1 or BXDC1 resulted in a major
reduction in the amount of RPL5 in the nucleolus (Figure 4). In
contrast, only knockdown of BXDC1 affected the nucleolar local-
ization of RPL11. However, a common feature of depletion of
either RRS1 or BXDC1 was an increase in the nucleoplasmic
accumulation of both RPL5 and RPL11. The knockdown of
PICT1, PAK1IP1, NOP2, or BOP1 did not significantly affect
the distribution of RPL5 in the cell. In contrast, depletion of any
of these proteins resulted in an increased relocation of RPL11
from the cytoplasm to the nucleoplasm but no significant change
in the amount present in the nucleolus. Surprisingly, depletion of
TFIIIA did not alter the localization of either RPL5 or RPL11,
although this knockdown had a similar effect on rRNA biogenesisell Reports 5, 237–247, October 17, 2013 ª2013 The Authors 241
Figure 4. The Biogenesis Factors RRS1 and BXDC1 Are Required for Nucleolar Localization of the 5S RNP
Inducible HEK293 FLAG-RPL5 or FLAG-RPL11 cells were grown on coverslips and depleted of various 5S/ribosome biogenesis factors using RNAi. For the final
12 hr of the knockdown, tagged protein expression was induced and cells were fixed. Immunofluorescence was performed using antibodies to detect the FLAG-
tag (red/greyscale) and fibrillarin (green). Nuclear material was visualized by DAPI staining (blue). The scale bar represents 1 mm.
See also Table S1.to depleting PAK1IP1 (Figures 3B and 4). We conclude that, if the
5S rRNA is essential for RPL5 and RPL11 accumulation, it is
likely that knockdown of TFIIIA results simply in reduced levels
of the 5S RNP and does not cause its mislocalization.
Our data therefore indicate that, with the exception of
depleting TFIIIA, blocking large ribosomal subunit production
results in an increase in the nucleoplasmic levels of RPL11. Inter-
estingly, RRS1 and BXDC1 are important for the nucleolar local-
ization of RPL11 and RPL5, despite the fact that these proteins
are not associated with a nonribosomal 5S RNP complex as
they are in yeast (Zhang et al., 2007).
5S rRNA Integration into the Ribosome Is Slow
The amount of free 5S RNP in the cell must be strictly controlled
in order to maintain appropriate levels of p53 and to regulate the
rate of proliferation. The abundance of the free 5S RNP is influ-
enced by the rate of both 5S RNP synthesis and its integration
into the ribosome. Therefore, identification of factors that
mediate 5S RNP integration into the ribosome will be critical
for discovering key regulators of p53 in this pathway. We devel-
oped an assay with which 5S RNP recruitment into ribosomes
could be monitored. For this, HEK293 cells were pulse-labeled
with 32P orthophosphate and then incubated with normal media
for various time points over a 12 hr period. Extracts prepared
from these cells were then analyzed by glycerol gradient centri-
fugation followed by gel electrophoresis (Figures 5A and S4A).242 Cell Reports 5, 237–247, October 17, 2013 ª2013 The AuthorsAs observed for the steady-state 5S rRNA (Figure 2A), the newly
synthesized 5S rRNA was found in two pools: the ribosomal and
preribosomal complexes (fractions 9–20) and a free pool (frac-
tions 1–7). The percentage of the 5S rRNA in the free and ribo-
somal/preribosomal complexes was then calculated and plotted
relative to the processing of the 28S rRNA (Figure 5B).
Integration of the newly transcribed 5S rRNA into the ribosome
fractions was slow, with more than 40% of the 5S rRNA found in
the free pool after 6 hr and more than 30% still free after 12 hr. In
contrast, processing of the RNA-pol-I-transcribed precursor-
rRNAs into mature rRNAs, as measured by the accumulation of
28S rRNA, was 90% complete after 6 hr. The slow recruitment
of newly synthesized 5S rRNA into the ribosome is probably
due to the 5S rRNA being recruited from the large pool of free
5S rRNA naturally present in the nucleus (see Figure 2).
PICT1 and RPL11 Are Required for 5S RNP Integration
into the Ribosome
Using this recruitment assay, we then established which of the
potential 5S RNP biogenesis factors are required for 5S RNP
integration into the ribosome. For these experiments, cells
depleted of putative 5S RNP biogenesis factors were pulse-
labeled followed by a 6 hr chase to allow significant integration
of the newly synthesized 5S rRNA into ribosomes. We also
analyzed 5S integration into preribosomes in cells treated with
the chemotherapeutic agents ActD or 5FU, which block rRNA
Figure 5. The Tumor Suppressor PICT1
Directly Contacts the 5S rRNA andMediates
5S RNP Integration into the Ribosome
(A) HEK293 cells were pulse-labeled using 32P
orthophosphate then grown in unlabeled media
for 1, 3, 6, 9, or 12 hr before harvesting. Whole cell
extracts were separated by glycerol gradient
centrifugation. RNA from each fraction was ex-
tracted and analyzed by agarose-glyoxal and
acrylamide gel electrophoresis, and labeled RNA
was visualized using a phosphorimager. (Upper
panel: 1 hr; middle panel: 6 hr; lower panel: 6 hr).
(B) Levels of 5S and 28S rRNAs in free (pooled
fractions 1–7) and ribosomal (pooled fractions 9–
20) complexes were quantified at each time point.
(C) HEK293 cells transfected with siRNAs target-
ing various 5S/ribosome biogenesis factors or
treated with chemotherapeutic chemicals were
analyzed as in (A) using a 6 hr chase (upper panel).
The proportion of 5S rRNA in ribosomal com-
plexes (pooled fractions 9–20) was calculated
from at least three experiments (including that
shown) and is given graphically (lower panel). Error
bars indicate SD. Dashed line represents a base-
line (ActD treatment) to which other data can be
compared.
(D) HEK293 cells expressing FLAG-tagged 5S
biogenesis factors were UV crosslinked, and
covalently bound RNA-protein complexes were
purified. Copurified 5S and 5.8S rRNAs were
analyzed by northern blotting.
See also Tables S1 and S2 and Figure S4.transcription and processing, respectively. Extracts from these
cells were separated by glycerol gradient centrifugation; the
fractions representing the free and ribosomal complexes were
pooled and the RNA content analyzed and quantified (Figures
5C and S4B).
The integration of the 5S rRNA into ribosomal complexes was
reduced to about 20%of that seen in control cells after treatment
with ActD. We defined this as the background level of newly syn-
thesized 5S rRNA present in the ribosomal fractions in the
absence of pre-rRNAs. Interestingly, treatment of cells with
5FU, which blocks pre-rRNA processing but does not affect
the levels of the 47S, 45S, and 32S pre-rRNAs (Figure 3C), re-
sulted in a significant decrease in 5S rRNA integration into preri-
bosomes (Figure 5C), suggesting that one action of this inhibitor
is to block 5S RNP integration into ribosomes.
Knockdown of RPL11 or PICT1 resulted in a very strong reduc-
tion of 5S rRNA incorporation into ribosomes, similar to that seen
after treatment with ActD (Figure 5C). Depletion of either NOP2
or BOP1 also had a notable, but not as significant, effect on
5S rRNA integration into ribosomes. Reducing the levels of
PAK1IP1, RRS1, or BXDC1 resulted in only a slight reduction
of 5S rRNA integration. Although depleting these factors inhibits
production of ribosomes, this resulted in similar, or even
increased, levels of 32S pre-rRNA compared to control cells
and no significant change in total ribosome levels (Figure 3B),
demonstrating that formation of the large ribosomal subunit pre-
cursor into which the 5S RNP is integrated was not impaired.CFurthermore, knockdown of RRS1, PICT1, or RPL11 had a
similar effect on large ribosomal subunit production and 32S
pre-rRNA accumulation, but PICT1 and RPL11 depletion had a
significantly stronger influence on 5S rRNA integration into
ribosomal complexes. Knockdown of RRS1 or BXDC1 had sur-
prisingly little effect on 5S RNP recruitment into ribosomes
considering that both proteins are required for 5S RNP integra-
tion into the large ribosomal subunit in yeast (Zhang et al.,
2007). Interestingly, using siRNAs targeting TFIIIA or the 5S
rRNA, which blocked ribosome production to a similar extent
as depletion of PAK1IP1, resulted in a subtle but reproducible
increase in 5S rRNA integration into ribosomes (Figure 5C).
This is likely to reflect the fact that TFIIIA and 5S rRNA knock-
downs affect ribosome biogenesis by reducing 5S rRNA synthe-
sis, which would in turn decrease the free 5S rRNA pool leading
to an increased uptake of newlymade 5SRNP into the ribosome.
Our data show that RPL11, the putative tumor suppressor
PICT1, and to a lesser extent BOP1 and NOP2 are important
for the integration of the 5S RNP into the ribosome.
PICT1, RRS1, BXDC1, and TFIIIA Directly Contact the 5S
rRNA
We have successfully identified factors that are required for 5S
RNP localization (RRS1 and BXDC1) and integration into the
ribosome (RPL11 and PICT1). It is possible that these proteins
are directly involved in 5S RNP localization/incorporation, but
these effects could also be indirect and arise due to impairmentell Reports 5, 237–247, October 17, 2013 ª2013 The Authors 243
Figure 6. The 5S RNP Complex Is Required for p14ARF-Mediated
Activation of p53
(A) U2OS cells stably transfected with a plasmid expressing p14ARF were
untreated () or treated (+) with IPTG for 12 hr and then analyzed by western
blotting.
(B) Expression of p14ARF was induced (+) or not () in cells transfected with
siRNAs targeting 5S RNP components. Levels of p53 in three replicate
experiments were analyzed by western blotting and quantified. Error bars
indicate SD.
(C) The relative difference between p53 induction in response to p14ARF
overexpression in cells transfected with control siRNAs and those targeting 5S
RNP components was calculated based on the data shown in (B). Error bars
indicate SD.
(D) Control U2OS cells or those expressing p14ARF (as in [A]) were pulse-
labeled using 32P orthophosphate. RNA was analyzed by polyacrylamide and
agarose-glyoxal gel electrophoresis and visualized using a phosphorimager.
See also Tables S1 and S3.of other steps upstream of 5S RNP biogenesis. It is highly likely,
however, that factors that directly contact the 5S RNP are func-
tionally involved in 5S RNP recruitment or biogenesis. We there-
fore used the UV crosslinking and complex purification method,
described earlier for RPL5 and MDM2 (Figure 1D), to identify
biogenesis factors that bind the 5S rRNA. HEK293 cells stably
expressing FLAG-tagged RRS1, BXDC1, PICT1, NOP2, and
TFIIIA (Figure S4C) were irradiated with UV light and the proteins,
and any covalently bound RNAs, isolated using a denaturing,
two-step purification procedure. Coprecipitated rRNA was
then analyzed by northern blotting. The 5S rRNAwas crosslinked
to PICT1, TFIIIA, RRS1, and BXDC1 indicating that these pro-
teins directly contact this RNA (Figure 5D). Little or no 5S rRNA
was coprecipitated with either the FLAG-tag alone, FLAG-
RCL1 (a small subunit ribosome biogenesis factor), or when UV
crosslinking was omitted. NOP2 did not reliably precipitate 5S
rRNA above background levels.
These crosslinking data therefore confirm that PICT1 plays a
direct role in 5S RNP recruitment into the ribosome and that244 Cell Reports 5, 237–247, October 17, 2013 ª2013 The AuthorsRRS1 and BXDC1 regulate nucleolar localization of the 5S
RNP by contacting the complex.
The 5S RNP Is Required for the Activation of p53 by the
Tumor Suppressor p14ARF
In addition to the 5S RNP-dependent pathway characterized
above, p53 is also activated in response to many signals other
than nucleolar stress. Interestingly, it has recently been shown
that RPL11 is also important for the activation of p53 by the
tumor suppressor p14ARF following oncogenic stress (Dai
et al., 2012), suggesting that the 5S RNPmay coordinate p53 in-
duction in response to multiple stresses. We therefore tested
whether all the 5S RNP components are essential for the activity
of p14ARF. The levels of the 5S rRNA (via TFIIIA knockdown),
RPL11, or RPL5 were reduced by RNAi in U2OS cells in which
the expression of p14ARF could be induced (Llanos et al.,
2001), and the levels of p53 were then measured in the presence
or absence of p14ARF (Figures 6A and 6B).
In control cells, expression of p14ARF resulted in increased
levels of p53 as expected, but knockdown of RPL11 or RPL5
significantly reduced this response. The knockdown of TFIIIA,
which reduced but did not abolish 5S rRNA transcription, also
notably decreased p53 induction by p14ARF overexpression sug-
gesting that the 5S rRNA is also required for this response.
Importantly, in each of three experiments performed, p53 induc-
tion was reduced relative to the control and appeared significant
(Figure 6C). Our data therefore demonstrate that all the 5S RNP
components are essential for the full activity of the tumor sup-
pressor p14ARF. Furthermore, expression of p14ARF also inhibits
ribosome biogenesis (Bertwistle et al., 2004; Itahana et al., 2003;
Figure 6D). We propose that, in addition to directly inhibiting
MDM2, p14ARF also functions by increasing the amount of
nonribosomal 5S RNP by blocking ribosome production. This
highlights a central role for the 5S RNP in mediating crosstalk
between different pathways of p53 activation.
DISCUSSION
We describe a mechanism by which ribosome biogenesis is
directly coupled to cell proliferation, and we show that the abun-
dance of the 5S RNP determines the basal levels of p53 in the
cell. All three components of the 5S RNP, RPL5, RPL11, and
the 5S rRNA, probably as a trimeric complex, are required for
p53 activation in response to impaired ribosome production (Fig-
ure 7). After submission of ourmanuscript, the involvement of the
5S rRNA, as part of the 5S RNP, in the regulation of the MDM2-
p53 checkpoint was also reported by the Thomas laboratory
(Donati et al., 2013). Both papers come to the conclusion that
the 5S RNP regulates p53 in response to changes in ribosome
synthesis. Here, we also show that MDM2 directly binds the
5S rRNA in vivo and provide a detailed analysis of 5S RNP
composition and dynamics. Furthermore, we define direct roles
for PICT1 in 5S RNP integration into the ribosome and for RRS1
and BXDC1 in the nucleolar localization of 5S RNP components.
Our data also indicate that p53 activation by the tumor suppres-
sor p14ARF involves the 5S RNP, suggesting crosstalk between
the cellular responses to ribotoxic and oncogenic stress. Taken
together, these data identify the 5S RNP as a key coordinator of
Figure 7. The 5S RNP Regulates p53 Homeostasis and Its Activation
in Response to Nucleolar and p14ARF Overexpression
Schematic overview showing the central role of the 5S RNP in coupling the
pathway of ribosome biogenesis to cellular proliferation.the cellular responses to both pro- and antiproliferative signals
(Figure 7).
The 5S RNP Interacts with MDM2 and Regulates p53
The 5S RNP accumulates in the nucleoplasm when ribosome
biogenesis is blocked, where it associates with MDM2. Our
data show that the 5S rRNA directly contacts MDM2 and that
this interaction is increased when ribosome biogenesis is in-
hibited. Furthermore, the high level of the 5S rRNA/RPL5 com-
plex (>200,000 copies per cell) in the nucleoplasm of normal cells
is far in excess of most basic transcription factors indicating that
any interaction between the dimeric 5S rRNA/RPL5 complex and
MDM2 is unlikely to affect MDM2 activity. Therefore, the trimeric
5S RNP, rather than its individual components or subcomplexes,
is the central regulator of MDM2 and therefore p53, which is
consistent with earlier reports that both RPL5 and RPL11 are
required for p53 activation in response to ActD treatment
(Bursac et al., 2012; Fumagalli et al., 2012; Sun et al., 2010)
and the recent report that the 5S rRNA is also required for this
regulation (Donati et al., 2013). A 5S rRNA, RPL5, MDM2, p53,
and 5.8S rRNA complex was previously described (Marechal
et al., 1994). We do not find the 5.8S rRNA in any of our ‘‘nonri-
bosomal’’ 5S RNP complexes, and the presence of this rRNA,
which is not normally found outside the ribosome, may also indi-
cate coprecipitation of the large ribosomal subunit in the results
reported by Marechal et al. (1994).
Our data demonstrate that RPL5 is required for the accumula-
tion and 30 processing of the 5S rRNA, and it is likely that
interaction with the RPL5/5S rRNA serves to stabilize RPL11.
The abundance of the 5S rRNA/RPL5 complex in the cell, and
the evidence that RPL11 is synthesized in excess (Lam et al.,
2007), suggests that the binding of RPL11 to the 5S rRNA/
RPL5 complex represents a key step in the p53 response and
must be carefully regulated. In contrast to an earlier reportC(Bursac et al., 2012), but consistent with other observations
(Chakraborty et al., 2011), we see RPL11 and RPL5 accumulate
in the nucleoplasm when ribosome biogenesis is blocked, which
may, however, reflect a difference in cell types used in the
different studies.
Using an MDM2 mutant that has previously been demon-
strated to prevent interaction with both RPL5 andRPL11 (Macias
et al., 2010), we show that the direct interaction of the 5S rRNA
and MDM2 is dependent on the presence of RPL5 and RPL11.
Interestingly, using a different approach involving RNAi-medi-
ated depletion of 5S RNP components, Donati et al. (2013)
also demonstrate a mutually dependent interaction of the com-
plex components with MDM2. Thus, the findings of the two
papers are complementary and both come to the conclusion
that the assembled 5S RNP regulates MDM2 and thereby p53.
Factors Involved in Biogenesis of the Large Ribosomal
Subunit Regulate 5S RNP-Mediated Modulation of p53
Integration of the 5S RNP into the ribosome is essential for 28S
and 5.8S rRNA processing, meaning that production of the large
ribosomal subunit is closely coupled to the amount of free 5S
RNP in the cell and consequently to p53 levels. We find that de-
fects in ribosome production cause an increase in RPL11 levels
in the nucleoplasm and p53 activation in a 5S RNP-dependent
manner. Interestingly, our data demonstrate that the tumor sup-
pressor PICT1, which directly binds to the 5S rRNA in vivo in our
UV crosslinking experiment, is an essential ribosome biogenesis
factor that is directly responsible for 5S RNP integration into the
ribosome. This explains earlier observations that PICT1 directly
binds RPL11 and RPL5 in vitro and is essential for retaining
RPL11 in the nucleolus (Sasaki et al., 2011). NOP2 or BOP1
were also important for 5S RNP integration into the ribosome
but to a lesser extent. These factors could directly modulate
5S RNP integration, potentially by bridging interactions between
the 5S RNP and the preribosome, or alternatively be essential for
upstream steps in the process.
Much to our surprise, and in contrast to the situation in yeast
(Zhang et al., 2007), we found that neither RRS1 nor BXDC1
was associated with the 5S RNP outside the preribosome.
Furthermore, depletion of either of these proteins had little or
no impact on 5S RNP recruitment into the ribosome. It is, how-
ever, clear that these two proteins, which directly contact the
5S rRNA, have an important function in the nucleolar localization
of RPL5 or both RPL5 and RPL11 in humans. Surprisingly, this
reduction of RPL5 and/or RPL11 levels in the nucleolus has
only a minor effect on 5S RNP integration into the ribosome.
The 5S RNP Is Essential for the Cellular Response to
p14ARF Overexpression
RPL11 has been shown to bind p14ARF and form an RPL11/
p14ARF/MDM2/p53 complex that is required for complete
p14ARF-dependent suppression of MDM2 and activation of p53
(Dai et al., 2012). We show here that RPL5 and the 5S rRNA,
probably as part of the assembled 5S RNP complex, are also
important for this process (Figure 7). This supports results where
amutation (C305F) in the zinc finger ofMDM2,which cannot bind
RPL11 and RPL5, accelerates Myc-induced lymphomagenesis
in mice (Macias et al., 2010). It is well established that p14ARFell Reports 5, 237–247, October 17, 2013 ª2013 The Authors 245
induction inhibits ribosome biogenesis, primarily targeting
the production of the large ribosomal subunit (Figure 6). These
data imply that p14ARF predominantly functions by impeding
ribosome biogenesis, causing an increase in the levels of nonri-
bosomal 5S RNP (Figure 7). The 5S RNP, together with p14ARF,
would then inhibit MDM2 leading to p53 activation.
Regulation of p53 Homeostasis and Cellular
Proliferation by the 5S RNP
We have clearly shown that the amount of the nonribosomal 5S
RNP in the cell determines the basal level of the tumor suppres-
sor p53. This provides a means by which the rate of ribosome
biogenesis is coupled to p53 homeostasis and therefore to
cellular proliferation (Figure 7). However, Donati et al. (2013)
observe only a slight reduction in p53 levels upon depletion of
5S RNP components. This may reflect differences in the effi-
ciency or duration of siRNA-mediated knockdown of the various
components or the different siRNA treatment times. Differences
between transfection efficiencies may also explain why we
observed a clear defect on 5S rRNA levels and pre-rRNA pro-
cessing using the 5S rRNA-specific siRNA that was not observed
in the other publication (Donati et al., 2013). The 5S RNP is a
combined product of RNA pol II and RNA pol III, and the levels
of free 5S RNP in the cell directly relate to the processing of
the RNA-pol-I-transcribed rRNAs. The 5S RNP is therefore an
ideal marker to coordinate gene expression from all three RNA
polymerases and the rate of ribosome biogenesis, itself an
essential aspect of cellular growth. Furthermore, RPL11 has pre-
viously been shown to regulate the proproliferative factor, c-Myc
(Dai et al., 2007). We would suggest that c-Myc regulation is
mediated by the 5SRNP, andwe therefore propose this complex
to be a critical regulator of several cellular signaling pathways.
A number of ribosomopathies, including Diamond Blackfan
anemia, 5q syndrome, and Treacher Collins syndrome, all result
in misregulation of p53, probably due to impaired ribosome
production increasing the amount of nonribosomal 5S RNP (Fig-
ure 7; Fumagalli and Thomas, 2011). The increased levels of p53
cause apoptosis during facial development in Treacher Collins
syndrome (Jones et al., 2008). In Diamond Blackfan anemia
and 5q syndrome, anemia is predicted to result from an inability
to meet the increased demand for ribosomes during erythropoi-
esis (Boultwood et al., 2012). Paradoxically, many of these dis-
eases also result in an increased propensity for cancer (Freed
et al., 2010; Narla and Ebert, 2010). However, it is possible that
either the p53 response becomes desensitized or that the cells
adapt to high p53 levels. Our data, therefore, highlight the 5S
RNP as a future target for anticancer and antiribosomopathy
drugs.
EXPERIMENTAL PROCEDURES
RNAi and the Analysis of rRNA Processing
HEK293 cell, U2OS cells, or U2OS cells expressing p14ARF under the control of
an isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible promoter (Llanos
et al., 2001) were transfected with siRNAs (see Table S1) using RNAiMAX Lip-
ofectamine. Harvested cells were analyzed by northern or western blotting
(see Tables S2 and S3). For pulse-labeling experiments, cells were treated
with siRNAs or chemotherapeutic agents (ActD and 5FU) and then pulse-
labeled with 32P orthophosphate (Sloan et al., 2013). RNAs extracted from246 Cell Reports 5, 237–247, October 17, 2013 ª2013 The Authorsthe cells were analyzed by agarose-glyoxal and denaturing-polyacrylamide
gel electrophoresis.
Immunoprecipitation and Glycerol Gradient Analysis
Whole cell extracts were separated on 10%–40% glycerol gradients, and the
resultant fractions analyzed by gel electrophoresis followed by western/north-
ern blotting or, in the case of labeled RNAs, phosphorimager analysis. Immu-
noprecipitation reactions were performed with whole cell extracts or pooled
gradient fractions using either an anti-FLAG antibody or anti-MDM2 anti-
bodies. Coprecipitated RNAs were extracted and analyzed by northern
blotting.
Immunofluorescence
HEK293 cell lines stably expressing inducible FLAG-tagged RPL5 or RPL11
were treated with ActD or specific siRNAs and then analyzed by immunoflu-
orescence using anti-FLAG and anti-fibrillarin antibodies. Images were
captured with a Zeiss Axiovert 200M inverted microscope.
UV Crosslinking of 5S rRNA and 5S RNP Biogenesis Factors
HEK293 cells expressing FLAG/His-tagged proteins of interest were UV
irradiated. Complexes were purified using anti-FLAG antibodies, eluted using
PreScission Protease, and then purified using nickel-nitrilotriacetic acid (NTA)
under denaturing conditions (6 M guanidium-HCl). Coprecipitated RNAs were
eluted using Proteinase K and analyzed by northern blotting.
See Extended Experimental Procedures for more information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, four
figures, and three tables and can be found with this article online at http://
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